Cadila Healthcare Latest News
-
Vinglyn is now one of the most affordable brands of Vildagliptin for diabetic patients in IndiaDate:12-12-2019
-
Vinglyn is now one of the most affordable brands of Vildagliptin for diabetic patients in IndiaDate:12-12-2019
-
Cadila Healthcare has informed about inspection by USFDA of the company’s API manufacturing facility located at Dabhasa, Gujarat and company received an Establishment Inspection Report (EIR) which stated that ...
Date:06-12-2019 -
The EIR report stated that the classification of the facility is ‘No Action Indicated (NAI)’Date:06-12-2019
-
The EIR report stated that the classification of the facility is ‘No Action Indicated (NAI)’Date:06-12-2019
-
There are currently no treatments available for the treatment of NASHDate:05-12-2019
-
Cadila Healthcare has informed about submission of a copy of press release dated December 5, 2019 titled ‘Zydus announces regulatory filing of Saroglitazar Magnesium for treatment of NASH with DCGI’. The contents of...
Date:05-12-2019 -
The drug is used together with diet and exercise to treat obesityDate:03-12-2019
-
The company has received an approval from the board of directors for the amalgamationDate:02-12-2019
-
The company has received an approval from the board of directors for the amalgamationDate:02-12-2019
SEBI Registered: Investment Adviser - 
+91 20 6725 8333